Surgery – Blood drawn and replaced or treated and returned to body – Constituent removed from blood and remainder returned to body
Reexamination Certificate
2005-09-20
2005-09-20
Sykes, Angela D. (Department: 3762)
Surgery
Blood drawn and replaced or treated and returned to body
Constituent removed from blood and remainder returned to body
C604S006010, C604S006110, C210S782000
Reexamination Certificate
active
06945948
ABSTRACT:
Methods and apparatus particularly involving the separation of blood into blood components and the collection of such components are disclosed. In one aspect, an extra-corporeal method for the collection of plasma and red blood cells is provided, wherein the collection of plasma and red blood cells may occur simultaneously or subsequently utilizing the same dual stage blood processing vessel. The flow of blood to the blood processing vessel and return of uncollected blood components may be provided via a single needle, wherein blood is removed from and returned to a donor/patient during alternating blood removal and blood return submodes. Platelet separation and collection options are also described. In either case, prior to red blood cell collection, a set-up phase may be carried out to set a predetermined hematocrit and AC ratio. Replacement fluid delivery may optionally also be provided either substantially continuously during any collection phase(s) and/or in a bolus mode.
REFERENCES:
patent: 3737096 (1973-06-01), Jones et al.
patent: 3946731 (1976-03-01), Lichtenstein
patent: 4010894 (1977-03-01), Kellogg et al.
patent: 4094461 (1978-06-01), Kellogg et al.
patent: 4114802 (1978-09-01), Brown
patent: 4120448 (1978-10-01), Cullis
patent: 4146172 (1979-03-01), Cullis et al.
patent: 4185629 (1980-01-01), Cullis et al.
patent: 4187979 (1980-02-01), Cullis et al.
patent: 4216770 (1980-08-01), Cullis et al.
patent: 4223672 (1980-09-01), Terman et al.
patent: 4263808 (1981-04-01), Bellotti et al.
patent: 4303193 (1981-12-01), Latham, Jr.
patent: 4370983 (1983-02-01), Lichtenstein
patent: 4379452 (1983-04-01), DeVries
patent: 4425112 (1984-01-01), Ito
patent: 4436620 (1984-03-01), Bellotti et al.
patent: 4479760 (1984-10-01), Bilstad et al.
patent: 4479761 (1984-10-01), Bilstad et al.
patent: 4526515 (1985-07-01), Devries
patent: 4626243 (1986-12-01), Singh et al.
patent: 4637813 (1987-01-01), Devries
patent: 4661246 (1987-04-01), Ash
patent: 4680025 (1987-07-01), Kruger et al.
patent: 4708712 (1987-11-01), Mulzet
patent: 4798090 (1989-01-01), Heath et al.
patent: 4804363 (1989-02-01), Valeri
patent: 4834890 (1989-05-01), Brown et al.
patent: 4851126 (1989-07-01), Schoendorfer
patent: 4897184 (1990-01-01), Shouldice et al.
patent: 4915848 (1990-04-01), Carmen et al.
patent: 4934995 (1990-06-01), Cullis
patent: 4968295 (1990-11-01), Neumann
patent: 4985153 (1991-01-01), Kuroda et al.
patent: 5076911 (1991-12-01), Brown et al.
patent: 5078671 (1992-01-01), Dennehey et al.
patent: RE33924 (1992-05-01), Valeri
patent: 5118428 (1992-06-01), Sand et al.
patent: 5120303 (1992-06-01), Hombrouckx
patent: 5121470 (1992-06-01), Trautman
patent: 5135667 (1992-08-01), Schoendorfer
patent: 5154716 (1992-10-01), Bauman et al.
patent: 5171456 (1992-12-01), Hwang et al.
patent: 5174894 (1992-12-01), Ohsawa et al.
patent: 5178603 (1993-01-01), Prince
patent: 5188583 (1993-02-01), Guigan
patent: 5217426 (1993-06-01), Bacehowski et al.
patent: 5267956 (1993-12-01), Beuchat
patent: 5273517 (1993-12-01), Barone et al.
patent: 5316667 (1994-05-01), Brown et al.
patent: 5321800 (1994-06-01), Lesser
patent: 5348533 (1994-09-01), Papillon et al.
patent: 5360542 (1994-11-01), Williamson, IV et al.
patent: 5362291 (1994-11-01), Williamson, IV
patent: 5370802 (1994-12-01), Brown
patent: 5387187 (1995-02-01), Fell et al.
patent: 5432054 (1995-07-01), Saunders et al.
patent: 5441636 (1995-08-01), Chevallet et al.
patent: 5445506 (1995-08-01), Afflerbaugh et al.
patent: 5472621 (1995-12-01), Matkovich et al.
patent: 5494578 (1996-02-01), Brown et al.
patent: 5496265 (1996-03-01), Langley et al.
patent: 5505685 (1996-04-01), Antwiler
patent: 5523004 (1996-06-01), Tanokura et al.
patent: 5529691 (1996-06-01), Brown
patent: 5581687 (1996-12-01), Lyle et al.
patent: 5605842 (1997-02-01), Langley et al.
patent: 5607579 (1997-03-01), Latham, Jr. et al.
patent: 5614106 (1997-03-01), Payrat et al.
patent: 5628915 (1997-05-01), Brown et al.
patent: 5637082 (1997-06-01), Pages et al.
patent: 5653887 (1997-08-01), Wahl et al.
patent: 5693232 (1997-12-01), Brown et al.
patent: 5704888 (1998-01-01), Hlavinka et al.
patent: 5720716 (1998-02-01), Blakeslee et al.
patent: 5853382 (1998-12-01), Kingsley et al.
patent: 5865785 (1999-02-01), Bischof
patent: 5941842 (1999-08-01), Steele et al.
patent: 5951877 (1999-09-01), Langley et al.
patent: 5954971 (1999-09-01), Pages et al.
patent: 6007725 (1999-12-01), Brown
patent: 6080322 (2000-06-01), Deniega et al.
patent: 6730055 (2004-05-01), Bainbridge et al.
patent: 2636290 (1978-02-01), None
patent: 0096217 (1983-12-01), None
patent: 0165751 (1985-12-01), None
patent: 0214803 (1987-03-01), None
patent: 0233112 (1987-08-01), None
patent: WO 88/01880 (1988-03-01), None
patent: WO 88/05691 (1988-08-01), None
patent: 0284764 (1988-10-01), None
patent: 0303765 (1989-02-01), None
patent: WO 95/03107 (1995-02-01), None
patent: 2390173 (1978-04-01), None
patent: 2176717 (1987-01-01), None
patent: WO 93/12888 (1993-07-01), None
patent: WO 94/11093 (1994-05-01), None
“Red Cell Apheresis: Challenges For Donor And Blood Component Collection Management” 24th Congress International Congress Of Blood Transfusion Haemonetics Luncheon Seminar, Centre For Blood And Cancer Diseases, Berlin, Germany, Apr. 2, 1996.
Baxier Healthcare Corporation,CS-3000 Plus Parameter Changes, Operator's Manual,prior to Mar. 9, 2000, pp. 1-1-1-24, 4-1-4-3, 5-1-5-2, 8-1-8-22, 9-1-9-44, 12-12-12-36.
COBE BCT, Inc., COBE SPECTRA Apheresis System, Operator's Manual, Feb. 1991, pp. xi-xxvii, 1-1-1-53, 3A-1, 3A-8, 3A-11, 4A-1, 4A-39, 4B-1-4B-42, 9-1-9-4.
Fresenius Ag, Operating Instructions AS 104 Blood Cell Separator, 1990, pp. 0-1-05, 1-3-1-6, 1-23, 2-0-2-51, 3-1-3-14, 4-1-4-16, 7-1-7-11, 7-13.
Haemonatics Corporation,Haemonetics Mobile Collection System Owner's Operating and Maintenance Manuel,1991, pp. 1-2-7-14.
Haemonetics Corporation,MCS+ for RBC Apheresis: Two Unit Red Cells protocol,Chapter 6, , prior to Mar. 9, 2000, pp. 6-1 through 6-32.
Mathes et al, “Improved Red Cell Quality After Erythroplasmapheresis With MCS-3P”,Journal Of Clinical Apheresis, 9:183-188, 1994.
Terumo Medical Corporation,—“Now Make the Direct Connection for Sterile Connection”, Advertisement 1995 or earlier.
Valbonesl et al., “Multicomponent collection (MCS): a new trend in transfusion medicine”,The International Journal of Artificial Organs,vol. 17, No. 2, 1994, , pp. 66-69.
Valbonesi et al., “Single-Donor Platelet Concentrated Produced Along With Packed Red Blood Cells with the Haemonetics MCS 3: Preliminary Results”,Journal of Clinical Apheresis9:195-199, 1994.
Bainbridge Marlene
Butzke Scott D.
Gordon Timothy M.
Keller Muriel
McAteer Michael J.
Deak Leslie R.
Gambro Inc.
Merkling John R.
Sykes Angela D.
LandOfFree
Extra-corporeal dual stage blood processing method and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extra-corporeal dual stage blood processing method and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extra-corporeal dual stage blood processing method and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3434993